Leo F Verdonck - JoVE Visualize

Showing results (31-40 of 101) with videos related to

Pageof 11

Sort By:

Blood|February 21, 2004

The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myelomaHenk M Lokhorst, Kalung Wu, Leo F Verdonck, et al.

Blood|May 31, 2002

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantationJoost W J van Esser, Hubert G M Niesters, Bronno van der Holt, et al.

Blood|November 30, 2006

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)Leo F Verdonck, Annelise Notenboom, Daphne D de Jong, et al.

International Journal of Hematology|August 13, 2015

Adult-onset congenital thrombotic thrombocytopenic purpura caused by a novel compound heterozygous mutation of the ADAMTS13 geneJohannes G Krabbe, Evelien W M Kemna, Annuska L M Strunk, et al.

Haematologica|October 13, 2005

Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalitiesHanneke M van der Straaten, Anja van Biezen, Ronald Brand, et al.

Haematologica|November 21, 2007

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myelomaGösta Gahrton, Simona Iacobelli, Giuseppe Bandini, et al.

Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011

Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trialsNazik Rayman, King H Lam, Bronno van der Holt, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2015

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?Aleksandar Radujkovic, Cesare Guglielmi, Stefania Bergantini, et al.

British Journal of Haematology|August 30, 2002

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT)Tapani Ruutu, Jo Hermans, Dietger Niederwieser, et al.

Blood|July 2, 2002

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell doseCesare Guglielmi, William Arcese, Francesco Dazzi, et al.

Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:

Pageof 11

Blood|February 21, 2004

The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myelomaHenk M Lokhorst, Kalung Wu, Leo F Verdonck, et al.

Blood|May 31, 2002

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantationJoost W J van Esser, Hubert G M Niesters, Bronno van der Holt, et al.

Blood|November 30, 2006

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)Leo F Verdonck, Annelise Notenboom, Daphne D de Jong, et al.

International Journal of Hematology|August 13, 2015

Adult-onset congenital thrombotic thrombocytopenic purpura caused by a novel compound heterozygous mutation of the ADAMTS13 geneJohannes G Krabbe, Evelien W M Kemna, Annuska L M Strunk, et al.

Haematologica|October 13, 2005

Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalitiesHanneke M van der Straaten, Anja van Biezen, Ronald Brand, et al.

Haematologica|November 21, 2007

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myelomaGösta Gahrton, Simona Iacobelli, Giuseppe Bandini, et al.

Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011

Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trialsNazik Rayman, King H Lam, Bronno van der Holt, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2015

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?Aleksandar Radujkovic, Cesare Guglielmi, Stefania Bergantini, et al.

British Journal of Haematology|August 30, 2002

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT)Tapani Ruutu, Jo Hermans, Dietger Niederwieser, et al.

Blood|July 2, 2002

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell doseCesare Guglielmi, William Arcese, Francesco Dazzi, et al.

Pageof 11